- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: JNJ-54452840
Total 867 results
-
Janssen Research & Development, LLCActive, not recruiting
-
Janssen Scientific Affairs, LLCApproved for marketingAdvanced Cancers and FGFR Genetic Alterations
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid TumorFrance, United States, Japan, Belgium, United Kingdom, Germany, Korea, Republic of, Taiwan, China, Poland, Italy, Spain, Australia, Brazil, Argentina
-
Janssen Vaccines & Prevention B.V.CompletedCOVID-19 PreventionUnited States, South Africa, Brazil
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Germany, Netherlands, Spain
-
Janssen Research & Development, LLCWithdrawn
-
OHSU Knight Cancer InstituteOregon Health and Science University; Janssen, LP; The Leukemia and Lymphoma...TerminatedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAsthmaGermany, United Kingdom
-
Janssen Research & Development, LLCCompletedColitis, UlcerativeUnited States, Australia, France, Ukraine, Germany, Israel, Poland, Bulgaria, Romania, Russian Federation, Canada, Netherlands, Belgium, Hungary
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCNo longer available
-
Janssen Research & Development, LLCCompletedCarcinoma, HepatocellularChina, Taiwan, Korea, Republic of
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Janssen Sciences Ireland UCCompletedHealthy | Hepatitis, ChronicFrance, Taiwan, Spain, Belgium, Bulgaria, Malaysia, Romania, Germany, Georgia, Moldova, Republic of
-
M.D. Anderson Cancer CenterActive, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma | Castration-Resistant...United States
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorGermany, Netherlands
-
Janssen Pharmaceutical K.K.Active, not recruitingHematologic MalignanciesJapan
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Belgium, Korea, Republic of, China, Germany, Israel, Netherlands, Japan, Spain, France, Poland
-
Janssen Research & Development, LLCActive, not recruitingHematological MalignanciesCanada, United States, France, Italy, United Kingdom, Germany, Belgium, Netherlands, Spain, Sweden, China
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Research & Development, LLCActive, not recruitingNeoplasmsUnited Kingdom, Spain, United States, Russian Federation, Poland, Sweden, Moldova, Republic of
-
Janssen Research & Development, LLCRecruitingInvasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) PreventionUnited States, United Kingdom, Korea, Republic of, Taiwan, Canada, Denmark, France, Thailand, New Zealand, Spain, China, Israel, Germany, Colombia, India, Netherlands, Australia, Japan, Sweden, Czechia, Italy
-
Janssen Pharmaceutical K.K.Completed
-
Octimet Oncology N.V.Terminated
-
Janssen Research & Development, LLCCompletedNeoplasms | Colorectal Cancer | Advanced Solid Tumors | Non-small Cell Lung CancerFrance, United States
-
Johnson & Johnson Pharmaceutical Research & Development...Withdrawn
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Spain, Netherlands, Sweden, Denmark, France
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Ukraine, Argentina, Mexico, Romania, South Africa, Korea, Republic of, Russian Federation, Brazil, Puerto Rico, Hungary, Slovakia, Czechia
-
Janssen Research & Development, LLCCompleted
-
ActelionTerminatedPulmonary Arterial HypertensionGermany, Korea, Republic of, Israel, Singapore, United States, Russian Federation, Brazil, Netherlands, Malaysia, Saudi Arabia, United Kingdom, Hong Kong, France, United Arab Emirates, Argentina
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedKidney Failure, ChronicUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedTraumatic Brain InjuryFrance, Belgium
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCWithdrawn
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CancerUnited States, France, Germany, United Kingdom, Belgium, Taiwan, Spain, Israel, India, Romania, Korea, Republic of, Russian Federation, Turkey, Austria, Moldova, Republic of
-
Janssen Research & Development, LLCCompletedRespiratory Syncytial Virus InfectionsUnited States, Taiwan, Japan, Korea, Republic of, France, Mexico, Brazil, Sweden, Argentina, Ukraine, Canada, Spain, Germany, Poland, Belgium, Russian Federation, South Africa, Australia, Bulgaria
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedNeoplasmChina, Taiwan, Korea, Republic of